Metagenomi TherapeuticsMGX
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)
Metagenomi TherapeuticsMGX
0
0
(0%)
財務數據
損益表
- 0.12
- 0.11
- 0.20
- 0.12
- 0.10
- 0.04
- 0.09
- 0.09
- 0.04
- 0.01
- 0.29
- -10.00
- 79.30
- -42.45
- -16.50
- -57.07
- 106.28
- 1.72
- -54.83
- -68.09
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 1,248 | 3,911 | 8,659 | 8,513 | 4,127 | 9,614 | 11,514 | 20,008 | 11,159 | 12,399 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,248 | 3,911 | 8,659 | 8,513 | 4,127 | 9,614 | 11,514 | 20,008 | 11,159 | 12,399 |
營業費用 | 25,835 | 28,278 | 31,498 | 29,500 | 31,947 | 30,237 | 33,897 | 36,871 | 40,191 | 32,595 |
研發費用 | 19,300 | 21,501 | 25,283 | 22,507 | 25,142 | 23,164 | 26,256 | 28,320 | 31,439 | 24,755 |
推銷及管理費用 | 6,535 | 6,777 | 6,215 | 6,993 | 6,805 | 7,073 | 7,641 | 8,551 | 8,752 | 7,840 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -24,587 | -24,367 | -22,839 | -20,987 | -27,820 | -20,623 | -22,383 | -16,863 | -29,032 | -20,196 |
其他收入及費用 | - | 1,873 | 2,212 | 1,123 | 2,879 | -3,983 | 1,504 | 3,925 | 3,884 | 3,628 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -23,049 | -22,494 | -20,627 | -19,864 | -24,941 | -24,606 | -20,879 | -12,938 | -25,148 | -16,568 |
所得稅 | 10 | 34 | -234 | 44 | 98 | -1,208 | -2,106 | -2,199 | - | 2,726 |
稅後純益 | -23,059 | -22,528 | -20,393 | -19,908 | -25,039 | -23,398 | -18,773 | -10,739 | -25,148 | -19,294 |
基本每股稅後盈餘(元) | -0.61 | -0.59 | -0.55 | -0.54 | -0.68 | - | -0.51 | -0.29 | -1.19 | - |
稀釋每股稅後盈餘(元) | -0.61 | -0.60 | -0.55 | -0.53 | -0.68 | -0.63 | -0.49 | -0.05 | -1.19 | -5.67 |
基本平均股數(千股) | 37581.00 | 37480.00 | 37349.00 | 37156.00 | 37019.00 | - | 36766.00 | 36625.00 | 21137.00 | - |
稀釋平均股數(千股) | 37581.00 | 37480.00 | 37349.00 | 37156.00 | 37019.00 | - | 36766.00 | 36625.00 | 21137.00 | - |
還原基本每股稅後盈餘(元) | -0.61 | -0.59 | -0.55 | -0.54 | -0.68 | - | -0.51 | -0.29 | -1.19 | - |
還原稀釋每股稅後盈餘(元) | -0.61 | -0.60 | -0.55 | -0.53 | -0.68 | -0.63 | -0.49 | -0.05 | -1.19 | -5.67 |
還原基本平均股數(千股) | 37,581 | 37,480 | 37,349 | 37,156 | 37,019 | - | 36,766 | 36,625 | 21,137 | - |
還原稀釋平均股數(千股) | 37,581 | 37,480 | 37,349 | 37,156 | 37,019 | - | 36,766 | 36,625 | 21,137 | - |
EBITDA(千元) | -21,774 | -21,664 | -20,133 | -19,357 | -24,667 | -24,534 | -22,647 | -13,686 | -25,126 | -17,075 |